A global leader in providing technology enabled business solutions and services

A global leader in providing technology enabled business solutions and services.

Services
Partners
About Us
Careers
Contact Us

Register | Login

Welcome, | Log Out

Services
Partners
About Us
Careers
Contact Us

Home /
DVC LLC /
Publications

Back
More Links

DVC LLC

DynPort Home
About DynPort
Services
Success Stories
Partners
Newsroom
DynPort Careers
Events
Knowledge Library
Bugs and Drugs Blog

Publications

DynPort's scientific, technical and program management staff have years of experience in their fields, offering our clients a wide variety of expertise. View abstracts and selected presentations from our experts here.

|<

<

Page of

>

>|

Sort Title

A-Z Sort Ascending
Z-A Sort Descending
Filters

Sort Client

A-Z Sort Ascending
Z-A Sort Descending
Filters

Sort Date

Sort Reverse Chronologically
Sort Chronologically

|<

<

Page of

>

>|

Sort Title

A-Z Sort Ascending
Z-A Sort Descending
Filters

Sort Client

A-Z Sort Ascending
Z-A Sort Descending
Filters

Sort Date

Sort Reverse Chronologically
Sort Chronologically

Animal Models - Presentation - Choosing an Immunogenicity Bridge DVC CSO Dr. Mary Kate Hart presented on choosing an appropriate immunogenicity bridges in both animal and human models.
Animal Rule - Poster - Challenges Facing Sponsors (Vaccines) Efficacy testing using the Animal Rule could present a more complicated path to licensure.
Animal Rule - Presentation - Case Studies Challenges Associated with Licensure of Vaccines Under the FDA Animal Rule: Case Studies
Animal Rule - Presentation - State of the Industry DVC’s Dr. Doris Snow presented challenges with the FDA Animal Rule at the 8th Annual Biodefense Vaccines and Therapeutics Summit in 2010.
Animal Rule - Presentation - Vaccine Efficacy Case Studies DVC’s Jeffry Shearer presented case studies on Animal Model development for vaccine efficacy at the 8th Annual ASM Biodefense in 2010.
Anthrax rPA - Research - Phase 1 Study of Safety, Immunogenicity Phase 1 trial testing safety and immunogenicity of anthrax vaccine using recombinant E. coli-derived, B. anthracis protective antigen (rPA).
Bioinformatics - Presentation - Future of Medical Research Dr. Robert House identifies how bioinformatics will be important to help make sense of biological data.
Bioinformatics - White Paper - Future of Medical Research Bioinformatics has emerged to capture the information stored in living systems and help turn it into actionable technology.
Botulinum - Presentation - Efficacy of rBV A/B in NHPs Updates on development of a recombinant botulinum vaccine, being developed to prevent fatal inhalational botulism.
Botulinum - Research - Formulation of Heavy Chain BoNT Fragments To potentiate the immune response of a botulinum A/B vaccine, an aluminum containing adjuvant will be formulated with the two antigens.

CSC Recommendations

LOG OUT
EDIT PROFILE

Recommended Reading

Coca-Cola Supply Chain Management Success Story

Coca-Cola has dominated the beverage market for over a century, yet still values...

3D Printing and the Future of Manufacturing

CSC’s new report, 3D Printing and the Future of Manufacturing, explores the...

User Acceptance Testing

CSC’s User Acceptance Testing Services validate end-to-end business process, system...

How 3D Printing Will Turn Manufacturing on Its Head

3D printing is making its mark as it reshapes product development and manufacturing and...

ABOUT CSC
SUCCESS STORIES
CAREERS
GLOBAL ALLIANCES
NEWSROOM
INVESTOR RELATIONS

CSC WIRE

CSC Wins SPAWAR Systems Center Atlantic PII Pillar Contract
CSC to Report Third Quarter 2013 Results on Tuesday, February 5, 2013
CSC Wins GSA Email as a Service Blanket Purchase Agreements

Engage With Us

CSC Town Hall
View On-Demand Events

CSC Communities

Leading Edge Forum

Meet our Ingenious Minds

Feedback

Follow Us

CSC

Legal |
Privacy |
Site Map
© Computer Sciences Corp